Theoretical and phenomenological implications of R-parity violation in supersymmetric theories are discussed in the context of particle physics and cosmology. Fundamental aspects include the relation with continuous and discrete symmetries and the various allowed patterns of R-parity breaking. Recent developments on the generation of neutrino masses and mixings within different scenarios of R-parity violation are discussed. The possible contribution of Rparity-violating Yukawa couplings in processes involving virtual supersymmetric particles and the resulting constraints are reviewed. Finally, direct production of supersymmetric particles and their decays in the presence of R-parity-violating couplings is discussed together with a survey of existing constraints from collider experiments.To be submitted to Physics Reports
We study the effects of extra spacetime dimensions at intermediate mass scales, as expected in string theories with large-radius compactifications, and focus on the gauge and Yukawa couplings within the Minimal Supersymmetric Standard Model. We find that extra spacetime dimensions naturally lead to the appearance of grand unified theories at scales substantially below the usual GUT scale. Furthermore, we show that extra spacetime dimensions provide a natural mechanism for explaining the fermion mass hierarchy by permitting the Yukawa couplings to receive power-law corrections. We also discuss how proton-decay constraints may be addressed in this scenario, and suggest that proton-decay amplitudes may be exactly cancelled to all orders in perturbation theory as a result of new Kaluza-Klein selection rules corresponding to the extra
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.